Chong-xian Pan
Harvard University(US)
Publications by Year
Research Areas
AI in cancer detection, Radiomics and Machine Learning in Medical Imaging, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics
Most-Cited Works
- → Combination strategies to maximize the benefits of cancer immunotherapy(2021)633 cited
- → CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy(2022)603 cited
- → A smart and versatile theranostic nanomedicine platform based on nanoporphyrin(2014)412 cited
- → Humanized mice in studying efficacy and mechanisms of PD‐1‐targeted cancer immunotherapy(2017)349 cited
- → From Combinatorial Chemistry to Cancer-Targeting Peptides(2007)283 cited
- → Small cell carcinoma of the urinary bladder(2004)266 cited
- → Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy(2020)242 cited
- → Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status(2004)205 cited
- → Increasing cure rates of solid tumors by immune checkpoint inhibitors(2023)117 cited
- → MiR‐34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53‐Rb pathway status(2011)115 cited